Hyperdopaminergic behavioral spectrum in Parkinson's disease: A review

Rev Neurol (Paris). 2018 Nov;174(9):653-663. doi: 10.1016/j.neurol.2018.07.005. Epub 2018 Sep 14.

Abstract

Impulse control disorders (ICDs) and other related behaviors, such as punding and dopamine dysregulation syndrome, are frequent yet underrecognized non-motor complications of dopamine replacement therapy (DRT) in Parkinson's disease (PD); they can also have a major negative impact on quality of life. They result from complex interactions between a given individual's predispositions, non-physiological dopaminergic stimulation and PD pathology. Also, sensitization of the mesocorticolimbic pathway, reflected by the psychotropic effects of dopaminergic treatment, plays a crucial role in the emergence of these addictive behaviors. While early detection of changes in behavior, less use of dopamine agonists (DA) that have a relative selectivity for mesocorticolimbic dopamine receptors, and fractionation of levodopa dosages to avoid non-physiological pulsatile stimulation of dopamine receptors are key strategies in the management of this hyperdopaminergic behavioral spectrum, other complementary approaches are also addressed in this review.

Keywords: Behavioral addictions; Dopamine; Dopamine withdrawal syndrome; Impulse control disorders; Neuropsychiatric fluctuations; Parkinson's disease.

Publication types

  • Review

MeSH terms

  • Disruptive, Impulse Control, and Conduct Disorders / etiology
  • Disruptive, Impulse Control, and Conduct Disorders / psychology
  • Dopamine Agents / adverse effects*
  • Dopamine Agents / therapeutic use*
  • Dopamine*
  • Humans
  • Mental Disorders / etiology*
  • Mental Disorders / psychology*
  • Parkinson Disease / complications*
  • Parkinson Disease / drug therapy
  • Parkinson Disease / psychology*

Substances

  • Dopamine Agents
  • Dopamine